H-J Wang

406 total citations
11 papers, 285 citations indexed

About

H-J Wang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, H-J Wang has authored 11 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in H-J Wang's work include RNA modifications and cancer (2 papers), Circular RNAs in diseases (2 papers) and Cancer-related molecular mechanisms research (2 papers). H-J Wang is often cited by papers focused on RNA modifications and cancer (2 papers), Circular RNAs in diseases (2 papers) and Cancer-related molecular mechanisms research (2 papers). H-J Wang collaborates with scholars based in China, United Kingdom and Taiwan. H-J Wang's co-authors include R. G. Prinn, S. O'Doherty, P. G. Simmonds, P. J. Fraser, D. M. Cunnold, Ray F. Weiss, D. B. Ryall, Richard G. Derwent, G. A. Sturrock and B. R. Miller and has published in prestigious journals such as Journal of Geophysical Research Atmospheres, Oncogene and British Journal of Cancer.

In The Last Decade

H-J Wang

11 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H-J Wang China 8 144 84 77 60 36 11 285
Hongke Cai China 12 193 1.3× 118 1.4× 129 1.7× 138 2.3× 147 4.1× 43 560
Brian D. Griffith United States 10 128 0.9× 51 0.6× 46 0.6× 16 0.3× 30 0.8× 18 325
Peiyan Chen China 14 109 0.8× 225 2.7× 183 2.4× 33 0.6× 41 1.1× 40 540
Haoran Hu China 10 222 1.5× 42 0.5× 47 0.6× 137 2.3× 35 1.0× 36 474
Hinnerk Boriss Germany 9 160 1.1× 11 0.1× 31 0.4× 50 0.8× 86 2.4× 14 420
Shriram Venkatesan Singapore 11 184 1.3× 33 0.4× 33 0.4× 51 0.8× 58 1.6× 12 354
Somsubhra Nath India 16 330 2.3× 194 2.3× 166 2.2× 90 1.5× 136 3.8× 40 674
Ana Filipa Domingues Portugal 12 207 1.4× 65 0.8× 43 0.6× 33 0.6× 12 0.3× 18 429
K. Sakai Japan 7 131 0.9× 122 1.5× 44 0.6× 22 0.4× 30 0.8× 13 394
Zhenfa Zhang China 13 249 1.7× 99 1.2× 43 0.6× 229 3.8× 117 3.3× 25 526

Countries citing papers authored by H-J Wang

Since Specialization
Citations

This map shows the geographic impact of H-J Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H-J Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H-J Wang more than expected).

Fields of papers citing papers by H-J Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H-J Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H-J Wang. The network helps show where H-J Wang may publish in the future.

Co-authorship network of co-authors of H-J Wang

This figure shows the co-authorship network connecting the top 25 collaborators of H-J Wang. A scholar is included among the top collaborators of H-J Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H-J Wang. H-J Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wang, H-J, et al.. (2022). Inhibition of microRNA-543 alleviates sepsis-induced acute kidney injury via targeting Bcl-2.. PubMed. 26(7). 2305–2312. 9 indexed citations
3.
Wang, H-J, et al.. (2020). MiR-34a-5p inhibition attenuates LPS-induced endothelial cell injury by targeting FOXM1.. PubMed. 24(20). 10829–10838. 12 indexed citations
4.
Wang, H-J, et al.. (2020). MiR-32-5p knockdown inhibits epithelial to mesenchymal transition and renal fibrosis by targeting SMAD7 in diabetic nephropathy. Human & Experimental Toxicology. 40(4). 587–595. 11 indexed citations
5.
Wang, H-J, et al.. (2020). LncRNA SNHG17 promotes proliferation and invasion of ovarian cancer cells through up-regulating FOXA1.. PubMed. 24(18). 9282–9289. 10 indexed citations
6.
Ss, Li, Wei Zhou, Qinxiu Zhang, et al.. (2016). p62/SQSTM1 enhances breast cancer stem-like properties by stabilizing MYC mRNA. Oncogene. 36(3). 304–317. 67 indexed citations
7.
Wang, H-J, et al.. (2014). JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1alpha-mediated glucose metabolism ; JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1α-mediated glucose metabolism. 6 indexed citations
8.
Yan, Tong, et al.. (2003). Fouling in offshore areas southeast of the Zhujiang (Pearl) River Delta, the northern South China Sea. Acta Oceanologica Sinica. 22(2). 201–211. 7 indexed citations
9.
Wang, H-J, Bruce R. Troen, Angela M. Inzerillo, et al.. (2002). Differential effects of interleukin-6 receptor activation on intracellular signaling and bone resorption by isolated rat osteoclasts. Journal of Endocrinology. 173(3). 395–405. 21 indexed citations
10.
O'Doherty, S., P. G. Simmonds, D. M. Cunnold, et al.. (2001). In situ chloroform measurements at Advanced Global Atmospheric Gases Experiment atmospheric research stations from 1994 to 1998. Journal of Geophysical Research Atmospheres. 106(D17). 20429–20444. 90 indexed citations
11.
Lin, Pinpin, et al.. (2000). Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma. British Journal of Cancer. 82(4). 852–857. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026